Show Notes
In this interview with Terri DeNeui, we explore why the conversation around PCOS is shifting toward a broader understanding of metabolic health with the emerging term PMOS.
Rather than viewing irregular cycles, infertility, and hormone imbalances as isolated ovarian problems, we discuss how insulin resistance, gut health, inflammation, stress, and lifestyle factors may be driving many of the symptoms women experience. I also share why this updated perspective could change the way clinicians evaluate and support patients across different stages of life—not just during their reproductive years.
We also spend time talking about practical treatment considerations, from comprehensive lab testing and lifestyle interventions to the appropriate role of GLP-1 medications.
Topics We Cover in This Episode:
Why some experts are moving from the term PCOS to PMOS—and what that shift represents
How insulin resistance and gut health may influence hormone balance
Why irregular menstrual cycles deserve a broader metabolic evaluation
The role inflammation and stress may play in hormone-related symptoms
Why body composition can be a more meaningful measure than weight alone
How to think about GLP-1 medications as one tool rather than a complete solution
Practical lifestyle habits that support long-term metabolic and hormonal health
Why treating symptoms without addressing underlying metabolic dysfunction may leave important questions unanswered
If you're interested in a more comprehensive way of thinking about hormones, metabolism, and women's health, I think you'll find this conversation both practical and thought-provoking.
Order Dr. Cassie’s Book ‘Fix Your Gut, Fix Your Hormones’: https://guthormonefix.com/
Use code LISTEN10 for 10 % off your order on shopmodernendocrine.com
📲 Follow Dr. Cassie Smith & Modern Endocrine
💻 Website: https://www.modern-endocrine.com/
📸 Instagram: https://www.instagram.com/modernendocrine_/
🌟 Facebook: https://www.facebook.com/ModernEndocrine
📽️ YouTube: https://www.youtube.com/@modernendocrine
🕹️ TikTok: https://www.tiktok.com/@modernendocrine?lang=en
📰 Newsletter: https://linktr.ee/modernendocrine
➡️ Disclaimer: https://www.modernendocrineokc.com/disclaimer-6353
More from Hormones, Metabolism & You!
Dr. Anna Cabeca joins me to talk about why so many midlife women are told their labs are normal while they feel exhausted, foggy, and out of step with their own bodies. We talk about what shifts in perimenopause, how falling progesterone and insulin resistance can show up as everyday symptoms, and why Dr. Cabeca treats hormone imbalance as a metabolic question first.
What if I told you right now, this very moment, your body is carrying a chemical load that you have never been tested for, never been warned about, and never asked for? In this episode, I’m joined by Nick Pineault, author of The Non-Tinfoil Guide to EMF and creator of the documentary Body Burden: The Toxins We Carry, to talk about what “body burden” actually means and how the chemicals we encounter through our food, water, air, plastics, household products and technology may intersect with hormones, metabolism and overall health.
Dr. Monisha Bhanote joins me to talk about cellular health and resilience, and why fatigue, brain fog, digestive issues, and other everyday symptoms may be signals from our cells rather than things we should simply accept. We talk about her approach to cell care, cellular consciousness, and why health practices need to be personalized rather than copied from the latest trend.
What happens when you’re doing all the “right” things for your hormones and health, but you still don’t feel better? In this episode, I sit down with Dr. Neil Nathan to explore why underlying factors like mold, Lyme disease, inflammation, nervous system dysregulation, and detoxification challenges may complicate treatment.
Testosterone in women is finally getting more attention, but what does that actually mean for women and their care? In this episode, I sit down with Dr. Terri DeNeui to discuss the FDA’s focus on testosterone, why there still isn’t an FDA-approved testosterone treatment specifically for women, and the questions surrounding safety, dosing, and access.